P3 Health Partners Inc.(PIII)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

P3 Health Partners Inc. (PIII) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PIII at 36.5/100 on a 32-signal composite quality model, placing it at rank #2,268 of 2,962 stocks — the bottom half of the AI-ranked universe. PIII scores in the top quartile across institutional flow (96.6). Areas of concern include earnings quality (5.0) and balance sheet strength (14.0), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), P3 Health Partners Inc. reports quarterly revenue of $386.4M, net income of $7.4M. Top institutional holders of PIII by reported 13-F value include HRT FINANCIAL, JANE STREET GROUP, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. PIII trades on the Nasdaq exchange and files with the SEC under CIK 1832511. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PIII daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for P3 Health Partners Inc. directly from SEC EDGAR.

AI Quality Score

36.5/100

AI Rank

#2,268

Revenue

$386.4M

Net Income

$7.4M

PIII key financials by period

P3 Health Partners Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$1.5B$-147.9M-18.5%
FY 202410-K$1.5B$-135.8M-21.4%
FY 202310-K$1.3B$-57.8M-13.3%
FY 202210-K$1.0B$-270.1M-148.7%
FY 202010-K$491.1M$-31.4M-5.8%
FY 201910-K$145.5M$-42.0M-27.2%

Institutions holding PIII

Institutional investors reporting a position in P3 Health Partners Inc. on SEC Form 13F.
InstitutionSharesValueReported
HRT FINANCIAL54,717$590.0K2026-06-30
JANE STREET GROUP54,495$588.5K2026-06-30
VANGUARD CAPITAL MANAGEMENT41,484$448.0K2026-06-30
Trinity Financial Advisors33,540$362.2K2026-06-30
MYDA Advisors20,000$216.0K2026-06-30
Corient Private Wealth19,737$213.2K2026-06-30
GEODE CAPITAL MANAGEMENT17,096$184.7K2026-06-30
Scientech Research16,318$176.2K2026-06-30
Abundance Wealth Counselors16,000$172.8K2026-06-30
RENAISSANCE TECHNOLOGIES15,149$163.6K2026-06-30
PIII

P3 Health Partners Inc.

PIII
NasdaqSmall CapHealthcare

13F Pro Quality Score

36.5/100

Rank #2,268 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

39.2/100

Profitability

28.8/100

Balance Sheet

14.0/100

Earnings Quality

5.0/100

Free Cash Flow

17.5/100

Institutional Flow

96.6/100

Revenue Scale

58.0/100

Dilution Risk

79.2/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$386.38M

Net Income

Q2 2026
EDGAR

$7.44M

EPS (Diluted)

Q2 2026
EDGAR

$-0.63

Debt/Equity

Q2 2026
EDGAR

1.94

Top Institutional Holders

as of Q2 2026
$3.48M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…